溶酶体
光动力疗法
抗性(生态学)
医学
化学
生物
生态学
生物化学
有机化学
酶
作者
Hang Zou,Pingping Wang,Zhihao Bai,Liping Liu,Jingtong Wang,Yanfang Cheng,Bairong He,Zujin Zhao,Lei Zheng
标识
DOI:10.1016/j.mtbio.2025.101564
摘要
Therapeutic resistance is a major challenge in clinical cancer theranostics, often leading to treatment failure and increased patient mortality. Breaking this therapeutic deadlock, enhancing the efficacy of clinical treatments, and ultimately improving patient survival rates are both highly desirable and significantly challenging goals. Herein, we have developed a new fluorescent luminogen, QM-DMAC, which features aggregation-induced emission (AIE), and exceptional viscosity-responsive properties. The AIE-active QM-DMAC can specifically stain lysosomes in tumor cells, offering a high signal-to-noise ratio and enabling specific visualization of variations in lysosomal viscosity, such as those induced by inflammation or autophagy. Furthermore, QM-DMAC effectively generates reactive oxygen species (ROS) under white light irradiation, which precisely induces ROS-mediated lysosomal membrane permeabilization (LMP) and lysosome rupture. This ultimately causes severe cell damage and restores the sensitivity of tumor cells to radiotherapy and chemotherapy. Thus, QM-DMAC serves as a highly efficient lysosome-targeting photosensitizer and an excellent therapeutic sensitizer. This innovative “lysosome hijacking” strategy significantly maximizes the efficacy of photodynamic therapy, conquering therapeutic resistance and boosting the synergistic therapeutic effect when integrated with conventional radiotherapy or chemotherapy. It provides a novel approach to the design of theranostic agents for clinical cancer theranostics. An AIE-active lysosome-targeting therapeutic sensitizer has been developed. With satisfactory ROS generation capability, it can dramatically induce ROS-mediated lysosomal membrane permeabilization and specifically ablates tumors via photodynamic therapy. Furthermore, it restores the sensitivity of tumor cells to radiotherapy and chemotherapy, thereby overcoming therapeutic resistance, acting as an excellent therapeutic sensitizer and exhibiting extraordinarily impressive antitumor efficiency.
科研通智能强力驱动
Strongly Powered by AbleSci AI